IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice

A R Youssef, C R Shen, C L Lin, R N Barker, C J Elson

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

New Zealand Black (NZB) mice spontaneously develop autoimmune haemolytic anaemia (AIHA). Here the effect of injecting NZB mice with plasmids encoding IL-4 (pIL-4) or IL-10 (pIL-10) on NZB disease was tested. Both constructs delayed the development of anaemia as judged by increased haematocrit values as compared with controls, but neither altered the IgG1 to IgG2 red blood cell (RBC) bound autoantibody levels. The increased haematocrit value was associated temporally with increased RBC bound IgG in NZB mice treated with pIL-10, but not pIL-4. By contrast, up-regulation of splenic macrophage FcgammaRIIb2 mRNA was associated temporally with increased haematocrit values in NZB mice given pIL-4. However, no such increase occurred in NZB mice that inhaled a peptide containing a dominant T-cell epitope, although this treatment is known to bias the autoimmune response towards Th2 and to reduce the severity of anaemia. It is considered that IL-4 treatment, in part, ameliorates NZB anaemia by increasing the expression of the inhibitory FcgammaRIIb2 and thereby reducing the capacity of splenic macrophages to phagocytose autoantibody coated RBC, but that this mechanism does not explain the beneficial effects of the inhaled peptide.

Original languageEnglish
Pages (from-to)84-89
Number of pages6
JournalClinical and Experimental Immunology
Volume139
DOIs
Publication statusPublished - 2005

Keywords

  • IL-4
  • IL-10
  • autoimmune haemolytic anaemia
  • NZB mice
  • EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
  • T-CELL EPITOPE
  • FC-GAMMA-RIIB
  • ANTIERYTHROCYTE AUTOANTIBODY
  • INDUCED ARTHRITIS
  • TRANSGENIC MICE
  • B-1 CELLS
  • TH2 CELLS
  • IN-VIVO
  • INTERLEUKIN-10

Cite this

IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice. / Youssef, A R ; Shen, C R ; Lin, C L ; Barker, R N ; Elson, C J .

In: Clinical and Experimental Immunology, Vol. 139, 2005, p. 84-89.

Research output: Contribution to journalArticle

Youssef, A R ; Shen, C R ; Lin, C L ; Barker, R N ; Elson, C J . / IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice. In: Clinical and Experimental Immunology. 2005 ; Vol. 139. pp. 84-89.
@article{791fbce0344b4532b948e0a525772c1f,
title = "IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice",
abstract = "New Zealand Black (NZB) mice spontaneously develop autoimmune haemolytic anaemia (AIHA). Here the effect of injecting NZB mice with plasmids encoding IL-4 (pIL-4) or IL-10 (pIL-10) on NZB disease was tested. Both constructs delayed the development of anaemia as judged by increased haematocrit values as compared with controls, but neither altered the IgG1 to IgG2 red blood cell (RBC) bound autoantibody levels. The increased haematocrit value was associated temporally with increased RBC bound IgG in NZB mice treated with pIL-10, but not pIL-4. By contrast, up-regulation of splenic macrophage FcgammaRIIb2 mRNA was associated temporally with increased haematocrit values in NZB mice given pIL-4. However, no such increase occurred in NZB mice that inhaled a peptide containing a dominant T-cell epitope, although this treatment is known to bias the autoimmune response towards Th2 and to reduce the severity of anaemia. It is considered that IL-4 treatment, in part, ameliorates NZB anaemia by increasing the expression of the inhibitory FcgammaRIIb2 and thereby reducing the capacity of splenic macrophages to phagocytose autoantibody coated RBC, but that this mechanism does not explain the beneficial effects of the inhaled peptide.",
keywords = "IL-4, IL-10, autoimmune haemolytic anaemia, NZB mice, EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, T-CELL EPITOPE, FC-GAMMA-RIIB, ANTIERYTHROCYTE AUTOANTIBODY, INDUCED ARTHRITIS, TRANSGENIC MICE, B-1 CELLS, TH2 CELLS, IN-VIVO, INTERLEUKIN-10",
author = "Youssef, {A R} and Shen, {C R} and Lin, {C L} and Barker, {R N} and Elson, {C J}",
year = "2005",
doi = "10.1111/j.1365-2249.2004.02663.x",
language = "English",
volume = "139",
pages = "84--89",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - IL-4 and IL-10 modulate autoimmune haemolytic anaemia in NZB mice

AU - Youssef, A R

AU - Shen, C R

AU - Lin, C L

AU - Barker, R N

AU - Elson, C J

PY - 2005

Y1 - 2005

N2 - New Zealand Black (NZB) mice spontaneously develop autoimmune haemolytic anaemia (AIHA). Here the effect of injecting NZB mice with plasmids encoding IL-4 (pIL-4) or IL-10 (pIL-10) on NZB disease was tested. Both constructs delayed the development of anaemia as judged by increased haematocrit values as compared with controls, but neither altered the IgG1 to IgG2 red blood cell (RBC) bound autoantibody levels. The increased haematocrit value was associated temporally with increased RBC bound IgG in NZB mice treated with pIL-10, but not pIL-4. By contrast, up-regulation of splenic macrophage FcgammaRIIb2 mRNA was associated temporally with increased haematocrit values in NZB mice given pIL-4. However, no such increase occurred in NZB mice that inhaled a peptide containing a dominant T-cell epitope, although this treatment is known to bias the autoimmune response towards Th2 and to reduce the severity of anaemia. It is considered that IL-4 treatment, in part, ameliorates NZB anaemia by increasing the expression of the inhibitory FcgammaRIIb2 and thereby reducing the capacity of splenic macrophages to phagocytose autoantibody coated RBC, but that this mechanism does not explain the beneficial effects of the inhaled peptide.

AB - New Zealand Black (NZB) mice spontaneously develop autoimmune haemolytic anaemia (AIHA). Here the effect of injecting NZB mice with plasmids encoding IL-4 (pIL-4) or IL-10 (pIL-10) on NZB disease was tested. Both constructs delayed the development of anaemia as judged by increased haematocrit values as compared with controls, but neither altered the IgG1 to IgG2 red blood cell (RBC) bound autoantibody levels. The increased haematocrit value was associated temporally with increased RBC bound IgG in NZB mice treated with pIL-10, but not pIL-4. By contrast, up-regulation of splenic macrophage FcgammaRIIb2 mRNA was associated temporally with increased haematocrit values in NZB mice given pIL-4. However, no such increase occurred in NZB mice that inhaled a peptide containing a dominant T-cell epitope, although this treatment is known to bias the autoimmune response towards Th2 and to reduce the severity of anaemia. It is considered that IL-4 treatment, in part, ameliorates NZB anaemia by increasing the expression of the inhibitory FcgammaRIIb2 and thereby reducing the capacity of splenic macrophages to phagocytose autoantibody coated RBC, but that this mechanism does not explain the beneficial effects of the inhaled peptide.

KW - IL-4

KW - IL-10

KW - autoimmune haemolytic anaemia

KW - NZB mice

KW - EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS

KW - T-CELL EPITOPE

KW - FC-GAMMA-RIIB

KW - ANTIERYTHROCYTE AUTOANTIBODY

KW - INDUCED ARTHRITIS

KW - TRANSGENIC MICE

KW - B-1 CELLS

KW - TH2 CELLS

KW - IN-VIVO

KW - INTERLEUKIN-10

U2 - 10.1111/j.1365-2249.2004.02663.x

DO - 10.1111/j.1365-2249.2004.02663.x

M3 - Article

VL - 139

SP - 84

EP - 89

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

SN - 0009-9104

ER -